GCCM: Sessions has yet to issue new guidelines but currently we are affected by its impact.
CIM: Can you breakdown ownership % of Gulf Coast Canna Meds?
GCCM: Owned 100% by its shareholders.
CIM: What are the risks to investors, since Gulf Coast Canna Meds “touches the plant?
GCCM: Investing in start ups and early stage businesses involve risk including illiquidity, lack of dividends, loss of investment in dilution as well as inherent risk of investing in medical marijuana which is currently illegal under federal law.
CIM: Do you have an acquisition strategy or would you be an acquisition candidate?
GCCM: Not at this time.
CIM: How do you plan to scale your business throughout Florida?
GCCM: Our financial model shows us opening 3-4 new dispensaries each year.
CIM: Will you scale your operations to supply recreational marijuana when legal?
GCCM: We will evaluate that issue if presented.
CIM: What would be a major catalyst for Gulf Coast Canna Meds?
GCCM: Being awarded a Florida medical marijuana license.
CIM: What is your estimated growth rate over the next 5 years?
GCCM: $0M - $53M.
45